LDLR and familial hypercholesterolemia: Our study is the first to report the potential of brazilin from Caesalpinia sappan herb as a natural compound for the development of novel PCSK9 inhibitor, which could lead to new hypercholesterolemia drugs by disrupting the interaction between PCSK9 and LDLR.